ESSA Pharma Inc. Stock Company Profile
999 West Broadway, Suite 720
Vancouver BC V5Z 1K5
778-331-0962
www.essapharma.com
Industry: Biotechnology
Sector: Healthcare
Description
ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreements with Caris Life Sciences, Inc.; Bayer Consumer Care AG; Janssen Research & Development, LLC; and Astellas Pharma Inc. ESSA Pharma Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada.
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
